Overview
Wen-yi Wang practices practicing medicine in Taitung, Taiwan.
Their clinical expertise encompasses Nasopharyngeal Carcinoma, Mononucleosis, Glioma, and Gliomatosis Cerebri.
They are actively involved in clinical research, co-authoring 29 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wen-yi Wang
Is Wen-yi Wang a top-rated expert for Nasopharyngeal Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Wen-yi Wang is classified as an Experienced expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wen-yi Wang participate in research or clinical trials?
Yes. Wen-yi Wang has published 29 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Wen-yi Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- GliomaWang isExperienced. Learn about Glioma.
- Gliomatosis CerebriWang isExperienced. Learn about Gliomatosis Cerebri.
- MononucleosisWang isExperienced. Learn about Mononucleosis.
- Nasopharyngeal CarcinomaWang isExperienced. Learn about Nasopharyngeal Carcinoma.